CLINICAL_TRIALS
trial_result
· 2018-05-09
Clinical Trial Update: Implementation of PPI Medication PGX Testing [Phase 4]
Summary
Phase 4 trial update on implementing pharmacogenomic testing for proton pump inhibitor (PPI) medication in gastroesophageal reflux disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Nemours Children's Clinic | Conditions: Gastroesophageal Reflux | Phase 4 | Status: COMPLETED | Results posted: 2018-05-09